Yahoo Finance

Delcath Systems Announces Publication of Expert Narrative Review on Percutaneous Hepatic Perfusion for Liver Metastases from Uveal Melanoma

QUEENSBURY, N.Y., November 18, 2025--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), ("Delcath" or the "Company") an interventional oncology company focused on the treatment of primary and ...
National Institute for Health and Care Excellence

Melphalan chemosaturation with percutaneous hepatic artery perfusion and hepatic vein isolation for primary or metastatic cancer in the liver

The most common types of primary liver cancer are hepatocellular carcinoma (also known as hepatoma) and cholangiocarcinoma. However, cancer in the liver has often metastasised from other sites such as ...
ascopubs.org

Hepatic intra-arterial chemotherapy in patients with advanced hepatocellular and biliary tract carcinomas using a temporary percutaneous catheter.

Usefulness of preoperative F-18 FDG-PET/CT for detection of signet ring cell carcinoma of the stomach: Correlation with pathologic findings including immunohistochemical staining. Background: ...
Business Wire

Delcath Systems Announces Publication of 10-Year Single-Center Experience with Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), (“Delcath” or the “Company”) an interventional oncology company focused on the treatment of primary and metastatic liver ...
ascopubs.org

A phase III random assignment trial comparing percutaneous hepatic perfusion with melphalan (PHP-mel) to standard of care for patients with hepatic metastases from metastatic ...

Adjuvant therapy with pegylated interferon alfa-2b (36 months) versus low-dose interferon alfa-2b (18 months) in melanoma patients without macro-metastatic nodes: EADO trial. Background: Patients with ...
Medscape

Not All Leaking Bile Ducts Are Bile Leaks

Endoscopic retrograde cholangiopancreatography (ERCP) is indicated in both the diagnosis and the management of a bile duct leak following hepatobiliary surgery. In the following case, a history of ...
Morningstar

Delcath Systems Announces Publication of Expert Narrative Review on Percutaneous Hepatic Perfusion for Liver Metastases from Uveal Melanoma

Delcath Systems, Inc. (Nasdaq: DCTH), (“Delcath” or the “Company”) an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the publication ...